DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Comparison Between Two Different Dosages of Remifentanil During Colonoscopy

Information source: Ospedale San Raffaele
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Colonoscopy

Intervention: Remifentanil (Drug); Remifentanil (Drug); Meperidine (Drug)

Phase: Phase 4

Status: Completed

Sponsored by: Ospedale San Raffaele


The purpose of this randomized double-blind trial is to define the correct dosage of Remifentanil during operative and diagnostic endoscopic procedures. In particular we want to analyze if the administration of Remifentanil by PCSA (Patient Controlled Sedation and Analgesia) is a good method during colonoscopy, evaluating pain control, discharge time and side effects. 90 patients undergoing colonoscopy will be enrolled.

Clinical Details

Official title: Comparison Between Two Different Dosages of Remifentanil Administered by PCSA (Patient Controlled Sedation and Analgesia) and Meperidine During Colonoscopy: A Randomized Double-Blind Trial

Study design: Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Supportive Care

Primary outcome: Discharge Time, the Time to Reach a Modified Aldrete Score ≥18

Secondary outcome: Patient's Satisfaction


Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.


Inclusion Criteria:

- Adult Patients

- Diagnostic and Operative Colonoscopy

- ASA Physical Status I-II

Exclusion Criteria:

- Age < 18 years

Locations and Contacts

San Raffaele Hospital, Milan 20132, Italy
Additional Information

Starting date: April 2009
Last updated: January 2, 2012

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017